The artificial organ was able to monitor her glucose levels during pregnancy using a continuous glucose monitor (CGM) which in turn transmitted the information to an insulin pump that calculated and released the required amount of insulin into the body.
She is part of a study funded by the charity Diabetes UK. Three other women with artificial pancreas in the study, had had a caesarean section delivery.
Usually, diabetic mothers and infants born to diabetic mothers are prone to developing complications such as: foetal macrocosmia, impaired foetal growth, birth defects, pulmonary disease, stillbirths, preterm delivery amidst other complications that hamper chances of a normal vaginal delivery and perinatal outcomes.
Dr. Helen Murphy, lead author of the study said, "The artificial pancreas is an exciting new technology that may help us to treat diabetes in pregnancy and create a group of healthier mothers and babies."